International Open Access Journal Platform

脑电生物反馈治疗对精神分裂症患者阴性症状、社会功能及认知功能的影响

Effects of EEG Biofeedback Therapy on Negative Symptoms, Social Functioning, and Cognitive Function in Patients with Schizophrenia

Psychology of China / 2025,7(10): 1260-1264 / 2025-10-24 96 56

View Download PDF

• Authors: 潘瑶 汪永胜 胡谦 毛辉
• Information:

  宣城市第四人民医院，宣城

• Keywords:
  EEG biofeedback; Schizophrenia; Negative symptoms; Cognitive function
  脑电生物反馈; 精神分裂症; 阴性症状; 认知功能
• Abstract: Objective: To observe the effects of conventional psychiatric medication combined with EEG biofeedback therapy on negative symptoms, social functioning, and cognitive functioning in patients with schizophrenia. Methods: Patients with schizophrenia hospitalized at Xuancheng Fourth People’s Hospital between December 2023 and December 2024 were selected as study subjects. Assessments were conducted using a general demographic questionnaire, the Scale for the Assessment of Negative Symptoms (SANS), the Activities of Daily Living (ADL) scale, the Social Disability Screening Schedule (SDSS), and the Montreal Cognitive Assessment (MoCA) scale before the intervention, as well as at 4 weeks, 8 weeks, and 12 weeks after the intervention. Results: The MoCA scores of the two groups showed statistically significant differences in time effect, group effect, and time × group interaction effect (F=79.76, 6.43, 8.52, respectively; p<0.01). The SANS, ADL, and SDSS scores of both groups demonstrated statistically significant time effects (F=42.83, 13.79, 17.92, respectively; all p<0.01), but no statistically significant group effects (F=0.05, 2.28, 0.25, respectively; all p>0.05). However, the SANS, ADL, and SDSS scores showed statistically significant time × group interaction effects (F=25.86, 13.28, 14.90, respectively; all p<0.01). Further simple effect analysis revealed that at 8 and 12 weeks of intervention, the observation group had significantly lower SANS, ADL, and SDSS scores compared to the control group, with statistically significant differences (p<0.01). Conclusion: Conventional psychiatric medication combined with EEG biofeedback therapy can improve negative symptoms, daily living ability, social functioning, and cognitive functioning in patients with schizophrenia. 目的：观察精神科常规药物联合脑电生物反馈仪治疗对精神分裂症患者阴性症状、社会功能及认知功能的影响。方法：选取2023年12月至2024年12月于宣城市第四人民医院住院治疗的精神分裂症患者作为研究对象，采用一般人口学资料调查表、阴性症状评定量表（SANS）、日常生活能力量表（ADL）、社会功能缺陷量表（SDSS）和蒙特利尔认知评估量表（MoCA）于干预前、干预4周、干预8周及干预12周后进行评估。结果：两组患者MoCA评分在时间效应、组间效应和时间×组间交互效应上的差异具有统计学意义（F=79.76、6.43、8.52，p<0.01）；两组患者SANS、ADL和SDSS评分在时间效应上均有统计学意义（F=42.83、13.79、17.92，p均<0.01），两组患者SANS、ADL、SDSS评分在组间效应上的差异不具有统计学意义（F=0.05、2.28、0.25，p均>0.05）。两组患者SANS、ADL、SDSS评分在时间×组间交互效应上的差异均有统计学意义（F=25.86、13.28、14.90、8.52，p均<0.01）。进一步对评分进行简单效应分析结果显示，干预8周及第12周时观察组SANS、ADL、SDSS评分均低于对照组，且差异具有统计学意义（p<0.01）。结论：精神科常规药物联合脑电生物反馈仪治疗能够改善精神分裂症患者的阴性症状、日常生活能力、社会功能及认知功能。
• DOI: https://doi.org/10.35534/pc.0710205 (registering DOI)
• Cite: 潘瑶, 汪永胜, 胡谦, 毛辉. (2025). 脑电生物反馈治疗对精神分裂症患者阴性症状、社会功能及认知功能的影响. 中国心理学前沿, 7 (10), 1260-1264.